These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

602 related articles for article (PubMed ID: 23161153)

  • 1. Telomere shortening and Alzheimer's disease.
    Cai Z; Yan LJ; Ratka A
    Neuromolecular Med; 2013 Mar; 15(1):25-48. PubMed ID: 23161153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere shortening reduces Alzheimer's disease amyloid pathology in mice.
    Rolyan H; Scheffold A; Heinrich A; Begus-Nahrmann Y; Langkopf BH; Hölter SM; Vogt-Weisenhorn DM; Liss B; Wurst W; Lie DC; Thal DR; Biber K; Rudolph KL
    Brain; 2011 Jul; 134(Pt 7):2044-56. PubMed ID: 21672962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between chronic stress and Alzheimer's disease: Therapeutic effects of Saffron.
    Saeedi M; Rashidy-Pour A
    Biomed Pharmacother; 2021 Jan; 133():110995. PubMed ID: 33232931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ebselen ameliorates β-amyloid pathology, tau pathology, and cognitive impairment in triple-transgenic Alzheimer's disease mice.
    Xie Y; Tan Y; Zheng Y; Du X; Liu Q
    J Biol Inorg Chem; 2017 Aug; 22(6):851-865. PubMed ID: 28502066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
    J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.
    Dobarro M; Gerenu G; Ramírez MJ
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2245-57. PubMed ID: 23768694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Lithium Treatment Increases Telomere Length in Parietal Cortex and Hippocampus of Triple-Transgenic Alzheimer's Disease Mice.
    Cardillo GM; De-Paula VJR; Ikenaga EH; Costa LR; Catanozi S; Schaeffer EL; Gattaz WF; Kerr DS; Forlenza OV
    J Alzheimers Dis; 2018; 63(1):93-101. PubMed ID: 29614649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced Reelin expression accelerates amyloid-beta plaque formation and tau pathology in transgenic Alzheimer's disease mice.
    Kocherhans S; Madhusudan A; Doehner J; Breu KS; Nitsch RM; Fritschy JM; Knuesel I
    J Neurosci; 2010 Jul; 30(27):9228-40. PubMed ID: 20610758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telomere shortening reflecting physical aging is associated with cognitive decline and dementia conversion in mild cognitive impairment due to Alzheimer's disease.
    Koh SH; Choi SH; Jeong JH; Jang JW; Park KW; Kim EJ; Kim HJ; Hong JY; Yoon SJ; Yoon B; Kang JH; Lee JM; Park HH; Ha J; Suh YJ; Kang S
    Aging (Albany NY); 2020 Mar; 12(5):4407-4423. PubMed ID: 32126022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the superoxide dismutase/catalase mimetic EUK-207 in a mouse model of Alzheimer's disease: protection against and interruption of progression of amyloid and tau pathology and cognitive decline.
    Clausen A; Xu X; Bi X; Baudry M
    J Alzheimers Dis; 2012; 30(1):183-208. PubMed ID: 22406441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.
    Zhang ZH; Wu QY; Zheng R; Chen C; Chen Y; Liu Q; Hoffmann PR; Ni JZ; Song GL
    J Neurosci; 2017 Mar; 37(9):2449-2462. PubMed ID: 28137967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology.
    Isopi E; Granzotto A; Corona C; Bomba M; Ciavardelli D; Curcio M; Canzoniero LM; Navarra R; Lattanzio R; Piantelli M; Sensi SL
    Neurobiol Dis; 2015 Sep; 81():214-24. PubMed ID: 25434488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice.
    Sabogal-Guáqueta AM; Muñoz-Manco JI; Ramírez-Pineda JR; Lamprea-Rodriguez M; Osorio E; Cardona-Gómez GP
    Neuropharmacology; 2015 Jun; 93():134-45. PubMed ID: 25666032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of vitamin E administration on the elevated oxygen stress and the telomeric and subtelomeric status in Alzheimer's disease.
    Guan JZ; Guan WP; Maeda T; Makino N
    Gerontology; 2012; 58(1):62-9. PubMed ID: 21912072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt signaling loss accelerates the appearance of neuropathological hallmarks of Alzheimer's disease in J20-APP transgenic and wild-type mice.
    Tapia-Rojas C; Inestrosa NC
    J Neurochem; 2018 Feb; 144(4):443-465. PubMed ID: 29240990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic mild stress accelerates the onset and progression of the Alzheimer's disease phenotype in Tg2576 mice.
    Cuadrado-Tejedor M; Ricobaraza A; Frechilla D; Franco R; Pérez-Mediavilla A; Garcia-Osta A
    J Alzheimers Dis; 2012; 28(3):567-78. PubMed ID: 22045482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Approaches to Alzheimer's Disease Through Modulation of NRF2.
    Bahn G; Jo DG
    Neuromolecular Med; 2019 Mar; 21(1):1-11. PubMed ID: 30617737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic mouse models of Alzheimer's disease: phenotype and mechanisms of pathogenesis.
    Duff K
    Biochem Soc Symp; 2001; (67):195-202. PubMed ID: 11447835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.